Tannic acid inhibits diquat induced human renal HK-2 cells apoptosis through BAX/Bcl2/caspase/cleaved caspase-3 signaling pathway Authors: Maryam Radan, Narges Atefipour, Parnian Abedizadeh, Dian Dayer, Khojasteh Hoseinynejad Published: 2025 ABSTRACT AbstractBackgroundDiquat (DQ) exposure can cause acute kidney failure and rhabdomyolysis. Accordingly, the current study aimed to assess how DQ toxicity affects the viability of human proximal tubular cells (HK-2) and to evaluate the potential protective effects of Tannic acid (TA) in this experimental model.MethodsHK-2 cells were divided into groups: negative control, positive control, DQ alone, and DQ combined with TA at concentrations of 0.5, 2.5, and 5 μmol/L for 24 h. Subsequently, cell viability, reactive oxygen species (ROS) production, oxidative stress and inflammatory marker concentrations, as well as the expression of apoptosis-related genes, were evaluated in all groups.ResultsThe data indicate that DQ significantly increased ROS production and elevated the levels of malondialdehyde (MDA) and interleukin-6 (IL-6), which were associated with increased expression of BCL2 associated X protein (BAX) and cleaved caspase-3 genes in HK-2 cells. Additionally, DQ exposure led to significant decreases in total antioxidant capacity (TAC), interleukin-10 (IL-10) levels, and B-cell lymphoma 2 (Bcl-2) anti-apoptotic gene expression. TA treatment inhibited oxidative stress, inflammation, and apoptosis, likely through the BAX/Bcl-2 and caspase-3/cleaved caspase-3 signaling pathways in renal cells.ConclusionAccording to the results, TA treatment at all tested concentrations enhanced the expression of anti-apoptotic genes and suppressed cell apoptosis, thereby increasing renal cell viability.Graphical Abstract Supplementary InformationThe online version contains supplementary material available at 10.1186/s12938-025-01484-4.Keywords: Tannic acid, Diquat, Renal cell, Inflammation, Oxidative stress, Apoptosis Introduction Diquat (1,1'-Ethylene-2,2'-bipyridylium) is an herbicide that has gained widespread use in agricultural practices following the prohibition of parquet. Its toxic effects have been shown to cause injury to various tissues, including the lungs, liver, kidneys, and brain. As a result, the incidence of acute DQ poisoning has increased in recent years [1]. Currently available clinical data indicate that the dose–response relationship for DQ in humans is variable but that relatively small ingested volumes of concentrated formulations can produce severe toxicity. Human lethal doses have been estimated in the range of several grams (commonly reported as ≈6–12 g for concentrated formulations) [2–4]. In clinical series, ingestion of tens of milliliters of concentrated (≈20% w/v) DQ formulations (for example, ≈50–100 mL of a 20 g/100 mL product) has been associated with multi-organ injury and a high incidence of acute kidney injury [4, 5]. Reported blood DQ concentrations in seriously poisoned patients vary, but values on the order of 0.4–1.0 µg/mL have been documented in severe cases [6]. Although exact nephrotoxic threshold concentrations in humans are not firmly established, these clinical reports indicate that relatively modest oral ingestions of market formulations can deliver doses sufficient to cause renal accumulation and AKI, underscoring the clinical urgency for effective renal protective interventions. DQ circulates in the bloodstream and distributes to various organs and tissues throughout the body, with the highest concentrations found in the liver and kidneys [7]. Studies have indicated that bile contains DQ, suggesting that bile excretion may serve as a viable mechanism to reduce DQ concentrations in the serum and tissues long after ingestion [8]. Most patients with DQ poisoning exhibit damage and ulceration in the upper gastrointestinal tract, including the oral cavity and esophagus [9]. This initial injury is often followed by a range of complications, such as acute renal failure, impaired consciousness, seizures, heart failure, and liver damage, which occur after ingestion or exposure to a high dose of DQ over a short period [10, 11]. Research indicates that over 90% of DQ is excreted through the kidneys within 12–24 h following ingestion or exposure. In cases of significant consumption, symptoms of acute renal failure—including oliguria or anuria—may manifest, and in more severe instances, patients may die as a result of acute renal failure [10, 12]. The processes of redox cycling and the generation of ROS are believed to play crucial roles in the cytotoxic effects induced by bipyridyl herbicides [13]. Additionally, DQ radicals can react with various nucleophiles within cells, leading to direct damage to cellular components [8]. Research has shown that elevated doses of DQ not only induce oxidative stress and elevate ROS levels but also inhibit mitochondrial enzyme activity [14]. This mitochondrial dysfunction results in the release of mitochondria-associated proteins, including cytochrome c, the second mitochondrial-derived caspase activator Smac, and HtrA2. The release of cytochrome c can trigger the activation of caspase-3. The Bcl-2 family, a key regulator of apoptosis, plays a central role in controlling cytochrome c release and caspase-3 activation [15]. Studies have demonstrated that exposure to DQ leads to increased expression of pro-apoptotic proteins such as BAX and BAD, while downregulating the expression of the anti-apoptotic protein Bcl-2 [16]. Currently, the management of DQ poisoning and the development of effective therapeutic interventions remain at an early experimental stage. There is no specific antidote available for acute Diquat poisoning, nor is there an established standard treatment protocol [8]. While DQ exposure can lead to dysfunction or failure of various organs, the kidneys are primarily affected due to the high accumulation of DQ in renal tissue. It is important to note that DQ is metabolized mainly in the kidneys, making them the principal target organ in cases of poisoning [17]. Tannic acid, a member of the hydrolysable tannin family, is a plant-derived polyphenol characterized by a core structure of penta-O-galloyl-β-D-glucose (PGG) and multiple Gallic acid units [18]. Research has shown that TA provides various health benefits, including the reduction of serum cholesterol and triglyceride levels, as well as significant antioxidant properties [19]. The presence of numerous phenolic groups enables it to neutralize free radicals through electron transfer within the π-conjugated system. This capability makes TA and its derivatives highly effective in scavenging free radicals and mitigating oxidative stress-related damage [20, 21]. Currently, the clinical management of DQ poisoning remains largely supportive, as no specific antidote has been developed. Treatment approaches primarily focus on gastrointestinal decontamination, fluid replacement, and renal support through modalities such as hemodialysis or hemoperfusion, but their effectiveness is limited and often fails to prevent multi-organ failure. Antioxidants and anti-inflammatory agents, including N-acetylcysteine, vitamin C, and corticosteroids, have been used with varying degrees of success, yet no standardized therapeutic protocol exists. The high mortality rate associated with acute DQ intoxication highlights the urgent need for novel strategies that can mitigate oxidative stress, inflammation, and apoptosis, thereby improving patient outcomes. The selection of TA in this study was based on several considerations. First, TA is a naturally occurring hydrolysable polyphenol widely distributed in plants and consumed in the human diet, which makes it biocompatible and relatively safe. Second, it possesses a strong polyphenolic structure with multiple galloyl groups that enable potent free-radical scavenging and metal-chelating activity, conferring robust antioxidant potential. Third, previous studies have demonstrated its protective role against kidney injury in various experimental models, including ischemia–reperfusion and arsenic trioxide–induced nephrotoxicity, primarily through suppression of oxidative stress, inflammation, and apoptosis. Given that DQ toxicity involves excessive ROS generation, oxidative stress, and subsequent renal apoptosis, TA was a rational choice as a candidate protective compound for this experimental model. Given the known inhibitory effects of TA on oxidative stress and inflammation, we investigated its potential protective role against acute DQ-induced toxicity in human renal proximal tubular epithelial cells. Specifically, this study aimed to evaluate how DQ toxicity affects oxidative stress markers in HK-2 cells and to assess the potential protective effects of TA in this experimental model. Results Impact of DQ and TA treatment on HK-2 cell viability In the first step, cell viability was assessed using an inverted microscope, which showed that DQ treatment resulted in a noticeable decrease in cell numbers compared to the control group. Conversely, treatment with TA at all tested concentrations increased cell viability relative to the DQ group (Fig. 1). To further evaluate cell viability, an MTT assay was performed on HK-2 cells. The results revealed a significant reduction in cell viability in both the H₂O₂ and DQ groups compared to the control group (p < 0.001). However, treatment with TA significantly increased cell viability in the DQ + TA2.5 and DQ + TA5 groups (p < 0.001) when compared to the DQ group (Fig. 2). Microscope analysis of the viability of the HK-2 cells in response to DQ (25 μmol/L), DQ + TA 0.5 (DQ 25 μmol/L + TA 0.5 μmol/L), DQ + TA 2.5 (DQ 25 μmol/L + TA 2.5 μmol/L), DQ + TA 5 (DQ 25 μmol/L + TA 5 μmol/L) conditions Effect of TA on cell viability using MTT assay in all groups including: Negative control (PBS), Positive control (H₂O₂), DQ (25 μmol/L), DQ + TA 0.5 (DQ 25 μmol/L + TA 0.5 μmol/L), DQ + TA 2.5 (DQ 25 μmol/L + TA 2.5 μmol/L), and DQ + TA 5 (DQ 25 μmol/L + TA 5 μmol/L). Results are expressed as mean ± SEM. Statistical analysis was performed using one-way ANOVA followed by Tukey’s post hoc test. *p < 0.05, **p < 0.01, ***p < 0.001 vs. Control group; #p < 0.05, ##p < 0.01, ###p < 0.001 vs. DQ group Preliminary concentration–response analysis for DQ and TA To determine appropriate working concentrations, HK-2 cells were first exposed to various DQ concentrations (10–100 μM) for 24 h. As shown in Supplementary Figure S1A, cell viability decreased in a concentration-dependent manner, with approximately 57% viability at 25 μM and < 10% at 100 μM. Therefore, 25 μM was selected as the optimal concentration to induce measurable cytotoxicity without complete cell death. Similarly, TA concentrations ranging from 0.1 to 20 μM were tested in the presence or absence of DQ (25 μM). As illustrated in Supplementary Figure S1B, TA alone did not affect cell viability up to 10 μM, while co-treatment with DQ showed a dose-dependent protective effect starting from 0.5 μM and plateauing at 5 μM. Accordingly, 0.5, 2.5, and 5 μM were selected for subsequent experiments. Impact of DQ and TA treatment on ROS content As shown in Fig. 3, intracellular ROS levels were significantly elevated in the H₂O₂ and DQ groups compared to the control group (p < 0.001). Conversely, treatment with TA led to a significant reduction in ROS levels in the TA-treated groups compared to the DQ group (p < 0.01, p < 0.001). Effect of TA on intracellular ROS levels in all groups including: Negative control (PBS), Positive control (H₂O₂), DQ (25 μmol/L), DQ + TA 0.5 (DQ 25 μmol/L + TA 0.5 μmol/L), DQ + TA 2.5 (DQ 25 μmol/L + TA 2.5 μmol/L), and DQ + TA 5 (DQ 25 μmol/L + TA 5 μmol/L). Results are expressed as mean ± SEM. Statistical analysis was performed using one-way ANOVA followed by Tukey’s post hoc test. *p < 0.05, **p < 0.01, ***p < 0.001 vs. Control group; #p < 0.05, ##p < 0.01, ###p < 0.001 vs. DQ group Impact of DQ and TA treatment on oxidant factors ROS are known to react with cell membrane lipids, leading to lipid peroxidation. Consequently, in this study, MDA was quantified as a well-established biomarker of lipid peroxidation. Our results demonstrated that treatment with H₂O₂, a known oxidizing agent, and DQ resulted in a significant increase in MDA levels compared to the control group (p < 0.001). Notably, MDA levels were significantly reduced in the groups treated with TA (p < 0.01, p < 0.001), as shown in Fig. 4A. Additionally, data presented in Fig. 4B indicate a marked decrease in TAC in response to H₂O₂ and DQ treatment compared to the control group (p < 0.001). However, treatment with TA, a potent antioxidant, led to a significant increase in TAC levels in the DQ + TA groups (p < 0.05, p < 0.01). Effect of TA on A MDA and B TAC in all groups including: Negative control (PBS), Positive control (H₂O₂), DQ (25 μmol/L), DQ + TA 0.5 (DQ 25 μmol/L + TA 0.5 μmol/L), DQ + TA 2.5 (DQ 25 μmol/L + TA 2.5 μmol/L), and DQ + TA 5 (DQ 25 μmol/L + TA 5 μmol/L). Results are expressed as mean ± SEM. Statistical analysis was performed using one-way ANOVA followed by Tukey’s post hoc test. *p < 0.05, **p < 0.01, ***p < 0.001 vs. Control group; #p < 0.05, ##p < 0.01, ###p < 0.001 vs. DQ group Impact of DQ and TA treatment on inflammation As demonstrated in Fig. 5A, levels of IL-6, a pro-inflammatory cytokine, were significantly elevated following exposure to H₂O₂ and DQ compared to the control group (p < 0.001). In contrast, treatment with TA at a concentration of 5 μmol/L resulted in a significant reduction in IL-6 levels compared to the DQ group (p < 0.01). Similarly, Fig. 5B shows that IL-10, an anti-inflammatory cytokine, was significantly decreased in the H₂O₂ and DQ groups compared to the control group (p < 0.001). However, IL-10 levels significantly increased in the DQ + TA-treated groups following TA administration (p < 0.001) compared to the DQ group. Effect of TA on A IL-6 and B IL-10 in all groups including: Negative control (PBS), Positive control (H₂O₂), DQ (25 μmol/L), DQ + TA 0.5 (DQ 25 μmol/L + TA 0.5 μmol/L), DQ + TA 2.5 (DQ 25 μmol/L + TA 2.5 μmol/L), and DQ + TA 5 (DQ 25 μmol/L + TA 5 μmol/L). Results are expressed as mean ± SEM. Statistical analysis was performed using one-way ANOVA followed by Tukey’s post hoc test. *p < 0.05, **p < 0.01, ***p < 0.001 vs. Control group; #p < 0.05, ##p < 0.01, ###p < 0.001 vs. DQ group Impact of DQ and TA treatment on gene expression related to apoptosis As shown in Fig. 6A, exposure to H₂O₂ and DQ led to a significant increase in Bax gene expression compared to the control group (p < 0.001). Conversely, treatment with TA in the DQ + TA 0.5, DQ + TA 2.5, and DQ + TA 5 groups significantly reduced Bax expression relative to the DQ group (p < 0.01, p < 0.001, and p < 0.001, respectively). Following 24 h of incubation with H₂O₂ and DQ, a significant decrease in Bcl-2 gene expression was observed compared to the control group (p < 0.001). However, TA treatment in the DQ + TA groups markedly increased Bcl-2 expression compared to the DQ group (p < 0.001), as shown in Fig. 6B. The results presented in Fig. 6C show a significant reduction in procaspase-3 gene expression in both the H₂O₂ and DQ groups relative to the control (p < 0.001). In contrast, the DQ + TA-treated groups exhibited a significant increase in procaspase-3 expression compared to the DQ group (p < 0.01, p < 0.01, and p < 0.001, respectively). The specificity of each qRT-PCR reaction was verified by melting-curve analysis, which revealed a single, sharp peak for all target genes (Bax, Bcl-2, and Caspase-3) and the reference gene (GAPDH), confirming the absence of nonspecific amplification or primer-dimer formation. The experimentally determined melting temperatures (Tm) of the amplicons were consistent with the values listed in Table 1. Effect of TA on A Bax, B Bcl-2 and C Caspase-3 genes expression in all groups including: Negative control (PBS), Positive control (H₂O₂), DQ (25 μmol/L), DQ + TA 0.5 (DQ 25 μmol/L + TA 0.5 μmol/L), DQ + TA 2.5 (DQ 25 μmol/L + TA 2.5 μmol/L), and DQ + TA 5 (DQ 25 μmol/L + TA 5 μmol/L). Results are expressed as mean ± SEM. Statistical analysis was performed using one-way ANOVA followed by Tukey’s post hoc test. *p < 0.05, **p < 0.01, ***p < 0.001 vs. Control group; #p < 0.05, ##p < 0.01, ###p < 0.001 vs. DQ group Table 1Primer sequences and experimentally determined melting temperatures (Tm) of amplicons used for qRT-PCR. The optimal annealing temperatures were obtained from gradient PCR (56–62 °C), and melting-curve analysis confirmed single, specific amplification peaksGeneAccession No. (Homo sapiens)Forward primer (5′–3′)Tm ≈ (°C)Reverse primer (5′–3′)Tm ≈ (°C)Product size (bp)GAPDHNM_002046.7 NCBITGCTGGTGCTGAGTATGTCGTG ~ 60–62CGGAGATGATGACCCTTTTGG ~ 58–60119BaxNM_004324.6*TTTGCTTCAGGGTTTCATCC ~ 57–59CAGTTGAAGTTGCCGTCAGA ~ 58–60144Bcl-2NM_000657.3*GACTTCGCCGAGATGTCCAG ~ 60–62GAACTCAAAGAAGGCCACAATC ~ 58–60135Caspase-3NM_004346.6*CCAAAGATCATACATGGAAGCG ~ 59–61CTGAATGTTTCCCTGAGGTTTG ~ 57–59136*Melting temperatures (Tm) were experimentally determined from melting-curve analyses following gradient PCR optimization (56–62 °C). Each gene displayed a single, sharp melt peak, confirming specific amplification and absence of primer-dimer formation Primer sequences and experimentally determined melting temperatures (Tm) of amplicons used for qRT-PCR. The optimal annealing temperatures were obtained from gradient PCR (56–62 °C), and melting-curve analysis confirmed single, specific amplification peaks *Melting temperatures (Tm) were experimentally determined from melting-curve analyses following gradient PCR optimization (56–62 °C). Each gene displayed a single, sharp melt peak, confirming specific amplification and absence of primer-dimer formation Impact of DQ and TA treatment on Caspase-3 and cleaved caspase-3 protein expression As shown in Fig. 7, Western blot analysis demonstrated that treatment with H₂O₂ or DQ markedly increased the expression of cleaved caspase-3 compared with the control group (***p < 0.001). In contrast, co-treatment with TA at all tested concentrations (0.5, 2.5, and 5 µM) significantly reduced cleaved caspase-3 expression relative to the DQ group (###p < 0.001). Notably, TA treatment restored cleaved caspase-3 levels close to those of the control group, suggesting a protective effect against DQ-induced apoptotic activation of caspase-3. Effect of TA on caspase-3/cleaved caspase-3 protein expression in all groups including: Negative control (PBS), Positive control (H₂O₂), DQ (25 μmol/L), DQ + TA 0.5 (DQ 25 μmol/L + TA 0.5 μmol/L), DQ + TA 2.5 (DQ 25 μmol/L + TA 2.5 μmol/L), and DQ + TA 5 (DQ 25 μmol/L + TA 5 μmol/L). Results are expressed as mean ± SEM. Statistical analysis was performed using one-way ANOVA followed by Tukey’s post hoc test. *p < 0.05, **p < 0.01, ***p < 0.001 vs. Control group; #p < 0.05, ##p < 0.01, ###p < 0.001 vs. DQ group Discussion DQ is a potent nephrotoxin, and the kidney is among the primary organs adversely affected following exposure. Clinical and experimental studies have consistently reported that renal tubular injury is a hallmark of DQ toxicity, largely due to its rapid accumulation in renal tissue and its role in generating excessive ROS. These events result in mitochondrial dysfunction, lipid peroxidation, and activation of intrinsic apoptotic pathways, ultimately contributing to acute kidney injury. The results of the current in vitro study revealed a significant reduction in cell viability in both the H₂O₂ and DQ groups compared to the control group (p < 0.001). Hydrogen peroxide was used as a positive control since it is a well-established inducer of oxidative stress and apoptosis in renal epithelial cell models [22, 23]. These results were associated with increased production of ROS and elevated MDA levels, an index of lipid peroxidation. Moreover, TAC showed a significant decrease in response to Diquat. A study by Wu et al. in 2022 showed that in a rat model of DQ exposure, cavitation bubbles became evident in the kidney at 24 h; the bilayer membrane structure of some mitochondria was lost, the podocytic processes of Sertoli cells were fused, dense deposits were observed in the basement membrane, and the number of lysosomes increased [24]. Another in vitro study by Magalhães in 2018 indicated that DQ compounds serve as significant producers of ROS through redox cycling and also promote lipid peroxidation [8]. The observed differences between hydrogen peroxide and DQ treatments can be explained by their distinct mechanisms of oxidative stress induction. Hydrogen peroxide acts as a direct oxidizing agent that rapidly diffuses across cell membranes and produces hydroxyl radicals via the Fenton reaction, leading to acute and severe oxidative injury that markedly reduces cell viability (approximately 50%). In contrast, DQ primarily undergoes redox cycling within the cell, continuously generating superoxide anions and downstream ROS. This process causes sustained oxidative stress, reflected by the high ROS-positive rate (around 90%) observed in the DQ group. However, because the redox cycling mechanism is somewhat slower and more progressive than the direct action of hydrogen peroxide, the overall loss of viability was less pronounced (around 70%). Thus, while both agents induced substantial ROS accumulation, the mode of action likely explains why hydrogen peroxide caused more immediate cytotoxicity compared to diquat, which triggered strong oxidative stress but relatively milder viability reduction within the same exposure period. In seeking to understand the mechanism of DQ toxicity, we evaluated inflammatory markers and apoptosis signaling pathways. The results indicated that IL-6 concentration levels were significantly increased in renal cells exposed to Diquat, while IL-10 levels were decreased compared to the control group. These changes positively correlated with increased expression of BAX and cleaved caspase-3 genes, alongside downregulation of Bcl-2 and procaspase-3 genes, which may be linked to the decreased viability of HK-2 cells caused by DQ toxicity. Similar findings have been reported in toxin-induced renal injury models, where increased IL-6 and BAX expression together with reduced IL-10 and Bcl-2 levels were associated with oxidative stress–mediated apoptosis [25, 26]. Phenolic compounds are currently recognized as some of the most significant natural antioxidants, playing a crucial role in mitigating diseases associated with oxidative stress [23]. TA is a plant-derived polyphenolic compound classified among hydrolysable tannins. Its structure features a core of penta-O-galloyl-beta-D-glucose along with multiple Gallic acid units [27]. Research has indicated that TA provides various health benefits, including the reduction of serum cholesterol and triglyceride levels, as well as potent antioxidant properties [28]. The presence of numerous phenolic groups on its periphery enhances the stability of its oxidized radical forms through electronic delocalization within the π-conjugated system [29]. Consequently, TA and its derivatives act as effective scavengers of ROS, thereby mitigating ischemia–reperfusion injury [30]. TA exerts anti-inflammatory activity mainly by modulating cytokine balance and signaling pathways. It downregulates pro-inflammatory mediators such as IL-6, TNF-α, and NF-κB activation, while simultaneously upregulating anti-inflammatory cytokines like IL-10. This dual action helps restore immune homeostasis and reduces tissue injury. Its anti-apoptotic effects are largely mediated through the intrinsic (mitochondrial) pathway: TA decreases the expression of pro-apoptotic proteins (e.g., Bax, cleaved caspase-3) and enhances anti-apoptotic proteins (e.g., Bcl-2), thereby stabilizing mitochondrial membranes, preventing cytochrome c release, and inhibiting caspase cascade activation. Additionally, TA can activate Nrf2 signaling, boosting endogenous antioxidant defenses that indirectly suppress both inflammation and apoptosis. Together, these mechanisms explain the protective effects observed in HK-2 cells exposed to Diquat. In this context, a study by Alechinsky et al. (2020) reported that TA enhanced renal recovery following warm ischemia, likely due to its antioxidant properties, which was consistent with decreased IL-6 and increased IL-10 levels [29]. Another study by Jin W et al. (2020) demonstrated that TA mitigates arsenic trioxide-induced nephrotoxicity by suppressing oxidative stress, inflammation, and apoptosis, likely via the NF-ΚB/Nrf2 signaling pathway [31]. Our findings revealed a dose-dependent improvement in oxidative stress, cytokine balance, and apoptotic gene expression with increasing concentrations of TA (0.5–5 μM). These concentrations were further supported by our preliminary dose–response experiments (Supplementary Fig. S1), which confirmed that 25 μM DQ induced moderate toxicity (~ 30% reduction in viability), and TA at 0.5–5 μM produced graded cytoprotective effects in a concentration-dependent manner, consistent with prior reports on renal and oxidative injury models (Alechinsky et al., 2020 [29]; Jin et al., 2020 [31]). Although complete concentration–response curves for both DQ and TA were beyond the scope of this study, the observed concentration-dependent effects strongly support the rationale behind our chosen doses. To the best of our knowledge, this report is the first to elucidate the protective role of TA against renal cell toxicity induced by DQ. Our findings indicate that TA may mitigate oxidative stress, inflammation, and apoptosis, likely through the BAX/Bcl-2 and caspase-3/cleaved caspase-3 signaling pathways. DQ exposure causes a marked increase in ROS generation that exceeds the physiological capacity of antioxidant enzymes, leading to their exhaustion and reduced activity, which in turn increases inflammation and apoptosis in HK-2 cells. In this study, TA treatment at all tested concentrations enhanced anti-apoptotic gene expression and suppressed cell apoptosis, resulting in increased renal cell viability. This study has some limitations that should be acknowledged. First, our findings are based on an in vitro HK-2 cell model, which may not fully replicate the complex pathophysiological processes occurring in vivo during DQ poisoning. Second, while we demonstrated the protective effects of TA at the cellular level, pharmacokinetic parameters, bioavailability, and potential systemic effects were not evaluated. Third, we assessed only a limited range of concentrations for both DQ and TA, and complete dose–response curves were not established. Finally, although our study demonstrated that TA modulates key regulators of the intrinsic apoptotic pathway—namely, decreased Bax and cleaved caspase-3 expression along with increased Bcl-2 and procaspase-3 levels—these findings represent molecular evidence of apoptosis suppression rather than direct quantification of apoptotic cell death. Future studies should therefore include direct phenotypic assays such as Annexin V–FITC/PI flow cytometry or TUNEL staining to confirm and quantify apoptosis inhibition at the cellular level. This additional evidence would further strengthen the mechanistic link between the observed molecular changes and functional anti-apoptotic effects. Conclusion Tannic acid treatment caused to inhibition of oxidative stress, inflammation, and apoptosis, likely via the BAX/bcl2 and caspase-3/cleaved caspase-3 signaling pathways in renel cells. According to the results, TA treatment in all concentrations enhanced anti-apoptotic genes expression and suppressed cell apoptosis which led to increases renal cell viability. Materials and methods Materials DQ and TA were purchased from Sigma-Aldrich (Germany). Hydrogen peroxide (H₂O₂) was obtained from Merck (Germany). The human renal tubular epithelial cell line (HK-2) was obtained from the Pasteur Institute of Iran (IPI). Dulbecco’s Modified Eagle Medium (DMEM), fetal bovine serum (FBS), penicillin, and streptomycin were purchased from Bio-Idea Co. (Iran). The MTT reagent and dimethyl sulfoxide (DMSO) were purchased from Sigma-Aldrich (Germany). The fluorescent probe 2′,7′-dichlorodihydrofluorescein diacetate (H₂DCFDA) for ROS detection was obtained from Thermo Fisher Scientific (USA). MDA and TAC assay kits, as well as IL-6 and IL-10 ELISA kits, were purchased from ZellBio (Germany). The RNA extraction kit, reverse transcriptase kit, and SYBR Green Master Mix were purchased from Kiagene (Iran). For Western blot analysis, primary antibodies against caspase-3 and cleaved caspase-3 (Asp175) and HRP-conjugated secondary antibodies were obtained from Cell Signaling Technology (USA). GAPDH antibody was purchased from Abcam (UK). RIPA lysis buffer, protease inhibitor cocktail, BCA protein assay kit, PVDF membranes, and enhanced chemiluminescence (ECL) reagents were purchased from Thermo Fisher Scientific (USA). All other reagents were of analytical grade and obtained from standard commercial suppliers. Experimental groups HK-2 cells were divided into six experimental groups: Negative control: PBS (100 μmol/L, 24 h). Positive control: H₂O₂ (100 μmol/L, 24 h). DQ: 25 μmol/L, 24 h. DQ + TA 0.5: DQ (25 μmol/L) + TA (0.5 μmol/L), 24 h. DQ + TA 2.5: DQ (25 μmol/L) + TA (2.5 μmol/L), 24 h. DQ + TA 5: DQ (25 μmol/L) + TA (5 μmol/L), 24 h. HK-2 cells were maintained in Dulbecco’s Modified Eagle Medium (DMEM, Bio-Idea Co., Iran) supplemented with 15% fetal bovine serum (FBS), 100 U/mL penicillin, and 100 μg/mL streptomycin. Cells were cultured at 37 °C in a humidified atmosphere containing 5% CO₂. Sub-culturing was performed at 70–80% confluence using 0.25% trypsin–EDTA, with a split ratio of 1:3 to 1:4, and cells were used for experiments between passages 3 and 8 to minimize variability. Culture medium was refreshed every 2–3 days. The concentration of 25 μM DQ was selected based on preliminary pilot tests in our laboratory (10–100 μM) as well as previous reports [8, 32], which showed that this dose reliably induced oxidative stress and apoptosis in HK-2 cells without causing complete loss of viability, thereby providing a suitable injury model. For TA, 0.5 μM was chosen as the minimum effective dose observed in pilot assays to exert antioxidant effects without cytotoxicity. The higher doses (2.5 and 5 μM) were selected to evaluate a concentration-dependent effect, consistent with protective ranges reported in earlier nephrotoxicity and ischemia–reperfusion studies [29, 31]. Cell viability assessment using the MTT method A colorimetric MTT assay was performed to evaluate the viability of HK-2 cells and to determine the cytotoxic effects of DQ as well as the protective potential of TA. HK-2 cells were seeded into 96-well plates at an appropriate density (1 × 10^4 cells per well) and allowed to adhere overnight under standard culture conditions (37 °C, 5% CO₂). The cells were then treated with DQ at a concentration of 25 μmol/L, either alone or in combination with varying concentrations of TA (0.5, 2.5, and 5 μmol/L), and incubated for 24 h. Following treatment, 30 μL of a freshly prepared MTT solution (5 mg/mL in PBS) was added to each well. The plates were then incubated for an additional 4 h at 37 °C to allow viable cells to reduce the yellow tetrazolium salt (MTT) to insoluble purple formazan crystals. After incubation, the culture medium was carefully removed to eliminate any unreacted MTT, and 150 μL of dimethyl sulfoxide (DMSO) was added to each well to dissolve the formazan crystals thoroughly, ensuring complete solubilization. The absorbance of each well was measured at 540 nm using a microplate ELISA reader (ELx808 Absorbance Microplate Reader, ELISA Technologies Inc., USA). Cell viability was expressed as a percentage relative to the negative control group using the following formula: All treatments were performed in triplicate, and the results were reported as mean ± standard deviation. ROS measurement using flow cytometry We employed flow cytometry to quantitatively measure intracellular ROS production using the fluorescent probe 2′,7′-dichlorodihydrofluorescein diacetate (H2DCFDA). HK-2 cells were incubated with H2DCFDA, a non-fluorescent cell-permeable compound that is converted intracellularly to 2′,7′-dichlorodihydrofluorescein (DCFH) by cellular esterases. Upon oxidation by ROS, DCFH is converted into the highly fluorescent 2′,7′-dichlorofluorescein (DCF), allowing the detection of ROS levels via fluorescence intensity. Briefly, following the treatment period, cells were washed and incubated with H₂DCFDA (at a concentration of 10 μM) for 30–45 min at 37 ℃ in the dark to prevent photobleaching. Subsequently, excess dye was removed by washing the cells with phosphate-buffered saline (PBS), and the cells were immediately analyzed using a flow cytometer. Fluorescence was excited at 488 nm, and emission was detected at 525 nm. The fluorescence intensity of DCF in each cell population was measured to assess ROS generation quantitatively. Appropriate controls were included, including unstained cells to measure autofluorescence and cells treated with known ROS inducers or scavengers to validate the assay. Data were collected for at least 10,000 events per sample and analyzed using flow cytometry software to determine the relative ROS levels in each experimental group. Measurement of TAC and MDA Levels of MDA, a biomarker of lipid peroxidation, and total antioxidant capacity, an overall indicator of the antioxidant status, were measured in the culture supernatants using commercially available assay kits (ZellBio, Germany). All procedures were performed following the manufacturer’s protocols. Briefly, after collecting the cell culture supernatants, samples were prepared as directed and subjected to colorimetric assays. The MDA assay quantifies thiobarbituric acid-reactive substances (TBARS), which form a colored complex with MDA, measurable by absorbance at the specified wavelength. TAC was determined based on the ability of antioxidants in the samples to reduce a defined oxidant, leading to a color change proportional to the total antioxidant content. Absorbance values were measured using a microplate reader at the wavelengths recommended by the kit instructions. Concentrations of MDA and TAC were calculated based on standard curves generated with known standards provided in the kits. Measurement of pro-inflammatory and anti-inflammatory cytokines In this purpose, the conclusion of the experiment, culture supernatants were collected and stored at –80 ℃ until analysis. The concentrations of IL-6, a pro-inflammatory cytokine, and IL-10, an anti-inflammatory cytokine, were quantified using commercially available enzyme-linked immunosorbent assay (ELISA) kits (ZellBio, Germany). The assays were performed following the manufacturer’s protocols, which utilize a sandwich ELISA format based on avidin–biotin chemistry for enhanced sensitivity and specificity. Briefly, samples and standards were added to microplate wells pre-coated with specific capture antibodies. After incubation and washing steps to remove unbound substances, biotinylated detection antibodies were applied, followed by avidin-conjugated enzyme treatment. A chromogenic substrate was then added, producing a color change proportional to the cytokine concentration in the samples. Absorbance was measured at the recommended wavelength using a microplate reader, and cytokine levels were calculated based on standard curves generated from known concentrations. Measurement of gene expression related to apoptosis Real-time quantitative PCR (qRT-PCR) was employed to evaluate the effects of DQ and TA on the expression levels of apoptosis-related genes, including Bax, Bcl-2, and Caspase-3 in HK-2 cells. Following treatment, cell lysates were collected, immediately flash-frozen in liquid nitrogen, and stored at –80 ℃ until further processing. Total RNA was extracted from the lysates using a commercially available RNA extraction kit (Kiagene, Iran), strictly adhering to the manufacturer’s protocol. The quality and concentration of extracted RNA were assessed using a spectrophotometer. Subsequently, complementary DNA (cDNA) was synthesized from 1 µg of total RNA using the Quantitate Reverse Transcriptase kit (Kiagene, Iran). Specific primers for the target genes and the reference housekeeping gene GAPDH (as an internal control) were designed and are listed in Table 1. qRT-PCR reactions were prepared in a total volume of 20 μL, consisting of cDNA template, gene-specific primers, SYBR Green Master Mix (Kiagene, Iran), and RNase-free distilled water. Amplification and detection were carried out using a Lava96 Real-time PCR Detection System (DaanGene Co., Ltd.). Thermal cycling conditions included an initial denaturation step, followed by 40 cycles of denaturation, annealing, and extension as per the kit recommendations. To optimize the annealing step, a temperature-gradient PCR (56–62 ℃) was first performed for each primer pair. The optimal annealing temperature was selected based on amplification efficiency and a single, sharp peak in the melting-curve analysis, confirming the specificity of the products and absence of primer-dimers. The experimentally determined melting temperatures (Tm) of the final amplicons were then used in the subsequent qRT-PCR runs. Melting curve analysis was performed to verify the specificity of the amplified products. Gene expression levels were quantified relative to the GAPDH housekeeping gene and calculated using the comparative threshold cycle (2^–ΔΔCT) method. All reactions were performed in triplicate to ensure reproducibility. Western blotting for cleaved caspase-3 Protein expression of caspase-3 and cleaved caspase-3 was evaluated by Western blotting. Cells were lysed in RIPA buffer containing protease and phosphatase inhibitors, and protein concentrations were determined using the BCA assay. Equal amounts of protein (20–30 µg) were separated by SDS-PAGE (12–15% gels) and transferred onto PVDF membranes. Membranes were blocked with 5% nonfat milk in TBST for 1 h at room temperature, then incubated overnight at 4 ℃ with primary antibodies against caspase-3 (full length) and cleaved caspase-3 (Asp175) (Cell Signaling Technology, cat. #9661). After washing, membranes were incubated with HRP-conjugated secondary antibodies for 1 h at room temperature. Bands were visualized using enhanced chemiluminescence (ECL) and imaged. GAPDH was used as a loading control. Densitometric analysis of band intensity was performed using, and the expression of caspase-3 and cleaved caspase-3 was normalized to the loading control. Statistical analysis The analysis of results was conducted utilizing SPSS software, with all data expressed as Mean ± SEM. The differences among the groups were assessed through one-way ANOVA, followed by post hoc Tukey’s test, with p < 0.05 was deemed statistically significant. Supplementary Information Supplementary material 1. Acknowledgements The authors of current article acknowledge the grant obtained from the) Cellular and Molecular Research Center, Medical Basic Sciences Research Institute, Ahvaz Jundishapur University of Medical Sciences, Ahvaz, Iran. ([Grant No. CMRC-0305 Ethic code: IR.AJUMS.MEDICINE.REC.1403.017]. Author contributions M. R conceptualized and designed the study, while N. A performed the data analysis and drafted the initial manuscript.P. A: reviewed and revised the manuscript and data interpretation. D. D: Statistical analysis and visualization. Kh. H: Supervision, project administration, and funding acquisition. All authors read and approved the final version of the manuscript. All authors take full responsibility for the content of this manuscript and have approved its submission. Funding This study was supported by Cellular and Molecular Research Center, Medical Basic Sciences Research Institute, Ahvaz Jundishapur University of Medical Sciences, Ahvaz, Iran [Grant No. CMRC-0305 Ethic code: IR.AJUMS.MEDICINE.REC.1403.017]. Data availability The datasets generated and analyzed during the current study (including MTT assay results, ROS measurements, cytokine assays, qRT-PCR and Western blot data) are not publicly available due to institutional policies but are available from the corresponding author on reasonable request. Declarations Ethics approval and consent to participate This study was approved by the Ethics Committee of the Cellular and Molecular Research Center, Medical Basic Sciences Research Institute, Ahvaz Jundishapur University of Medical Sciences, Ahvaz, Iran. Grant No. CMRC-0305 Ethic code: IR.AJUMS.MEDICINE.REC.1403.017. Consent for publication Not applicable. Competing interests The authors declare no competing interests. Footnotes Publisher's Note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations. References Associated Data Supplementary Materials Supplementary material 1. Data Availability Statement The datasets generated and analyzed during the current study (including MTT assay results, ROS measurements, cytokine assays, qRT-PCR and Western blot data) are not publicly available due to institutional policies but are available from the corresponding author on reasonable request.